Richa, Hanna .
HRN: 27-35-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
CEFUROXIME 750MG (VIAL)
06/22/2025
06/29/2025
IV
600mg
Q8
PCAP C
Pending Pharmacy Acceptance
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstreamProphylaxis Compliance to guidelines: